Christoph Schramm - Concepedia

Author

Christoph Schramm

Also Known As

C Schramm, C. M. Schramm, C. Schramm, Christian Rust, Christoph Schramm, Lohse, Ansgar W., P Milkiewicz, Schramm Christoph, Schramm, Christoph, Schramm, Christoph 1969-

636

Publications

21.9K

Citations

H-Index

183

Concepts

All Affiliations

Universität Hamburg University Medical Center Hamburg-Eppendorf Johannes Gutenberg University Mainz Medizinische Hochschule Hannover Christian-Albrechts-Universität zu Kiel

About

Christoph Schramm is an author at Universität Hamburg specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	65	9K
2	Health Sciences	4	4	248
3	Engineering	3	3	133
4	Public Health	3	3	301
5	Natural Sciences	1	1	48

Christoph Schramm

177

Publications

17.9K

Citations

H-Index

Page 1

	Year	Citations
Simplified criteria for the diagnosis of autoimmune hepatitis† Elke Hennes, Mikio Zeniya, Albert J. Czaja, Hepatology	2008	1.8K
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis Gideon M. Hirschfield, Ulrich Beuers, Christophe Corpechot, Journal of Hepatology Eus-guided Gallbladder DrainageHepatologyBiliary TractPrimary Sclerosing CholangitisBiliary Disorder	2017	1.4K
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling Christoph Becker, Massimo Claudio Fantini, Christoph Schramm, Immunity Tumor BiologyCancer ImmunosurveillanceMedicineImmunologyImmune Regulation	2004	716
The Translational Landscape of the Human Heart Sebastiaan van Heesch, Franziska Witte, Valentin Schneider-Lunitz, Cell Heart FailureStructural Heart DiseaseTranslational LandscapeAnthropologyMedicine	2019	631
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis Tobias J. Weismüller, Palak Trivedi, Annika Bergquist, Gastroenterology Autoimmune DiseaseBiliary TractGastroenterologyPathologyPrimary Sclerosing Cholangitis	2017	498
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas, Cell InflammationChronic Inflammatory DiseasesPhage ConsortiaDysbiosisIntestinal Inflammation	2022	465
Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells Samuel Huber, Christoph Schramm, Hans A. Lehr, The Journal of Immunology	2004	385
EASL Clinical Practice Guidelines on sclerosing cholangitis Olivier Chazouillères, Ulrich Beuers, Annika Bergquist, Journal of Hepatology HepatologyBiliary TractGastroenterologyPrimary Sclerosing CholangitisBiliary Disorder	2022	317
Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1 Ynto S. de Boer, Nicole M. F. van Gerven, Antonie Zwiers, Gastroenterology Genome-wide Association StudyAutoimmune DiseaseGenotype-phenotype AssociationGeneticsGenetic Epidemiology	2014	298
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis Peter Fickert, Gideon M. Hirschfield, Gerald Denk, Journal of Hepatology	2017	272

Page 1